Nu Skin Enterprises Inc

Consumer Defensive · Household & Personal Products

4.60$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Nu Skin Enterprises Inc (NUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,405 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NUS
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	332	352	606	643	591	582	612	624	610	679	665	683	710	748	892	991	1,153	1,821	1,614	1,506	1,474	1,590	1,694	1,769	1,957	1,906	1,821	1,806	1,469	1,405
Current Assets	280	276	355	283	222	238	276	277	268	308	277	266	290	338	423	530	599	1,118	835	706	714	778	799	740	903	873	760	702	539	548
Cash	207	166	189	110	64	76	120	123	110	155	121	87	115	158	230	273	320	525	288	289	357	426	387	336	403	340	265	256	187	239
Cash & Short-Term Investments	207	166	189	110	64	76	120	123	120	155	121	93	115	158	230	291	333	547	300	304	368	438	398	344	424	355	279	268	198	240
Receivables	17	20	36	35	18	32	19	15	16	17	19	23	16	23	26	32	37	69	36	35	31	33	53	50	63	41	47	73	51	40
Inventory	45	52	80	86	82	84	88	83	87	99	92	101	114	106	114	112	136	340	338	265	250	253	296	276	314	400	346	280	190	179
Property, Plant & Equipment	–	–	–	–	61	57	55	61	77	84	86	89	82	79	134	150	230	396	465	455	445	465	465	454	468	454	445	534	462	459
Goodwill	–	–	112	–	–	–	119	119	112	112	112	112	112	112	112	112	112	112	112	112	115	115	197	197	203	206	206	231	84	84
Intangible Assets	–	–	91	–	197	–	182	186	79	91	91	86	88	82	78	83	93	83	75	67	64	68	90	80	90	77	67	105	74	43
Total Liabilities	224	175	352	334	224	202	225	333	314	324	346	408	394	373	421	417	562	962	672	680	810	885	913	894	1,063	994	924	984	817	600
Current Liabilities	214	175	190	208	99	85	96	133	151	159	168	171	166	185	216	241	320	777	418	408	399	447	440	357	543	530	359	329	297	264
Short-Term Debt	82	20	15	56	–	–	–	18	19	27	27	31	30	35	28	29	39	68	83	68	83	78	69	67	75	141	54	49	48	38
Accounts Payable	6.6	23	18	23	16	15	18	19	25	20	21	24	20	25	25	32	48	83	35	29	41	50	48	39	66	50	54	43	35	26
Long-Term Debt	–	–	–	–	85	74	82	147	133	123	136	169	159	121	133	108	155	114	165	182	334	311	361	334	305	269	377	478	364	204
Shareholders' Equity	108	178	255	309	367	380	386	290	296	355	319	275	316	376	471	574	591	859	942	826	664	705	782	875	894	913	897	822	651	805
Retained Earnings	12	105	158	245	306	340	386	432	478	527	532	547	584	645	750	867	1,040	1,334	1,442	1,494	1,559	1,609	1,636	1,728	1,841	1,912	1,939	1,870	1,712	1,860
Shares Outstanding	83	87	87	88	86	84	83	80	73	71	71	66	64	64	65	65	63	61	61	59	56	55	56	56	53	51	51	50	50	50

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings